Cargando…
Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID
Autores principales: | Gabryszewski, Stanislaw J., England, Ross N., Sun, Di, Gentile, Tatiana Londoño, Hochgertel, William, Jyonouchi, Soma, Silverman, Michael, Zaoutis, Theoklis, Sullivan, Kathleen E., Henrickson, Sarah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380096/ https://www.ncbi.nlm.nih.gov/pubmed/34420125 http://dx.doi.org/10.1007/s10875-021-01093-5 |
Ejemplares similares
-
M406 SELF-LIMITED COVID-19 INFECTION IN ARTEMIS HYPOMORPHIC SCID: ARE B CELLS DISPENSABLE?
por: Gabryszewski, S., et al.
Publicado: (2020) -
Impact of a hypomorphic Artemis disease allele on lymphocyte development, DNA end processing, and genome stability
por: Huang, Ying, et al.
Publicado: (2009) -
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019) -
The ARTEMIS mission
por: Russell, Christopher, et al.
Publicado: (2014) -
Asymptomatic Infant With Atypical SCID and Novel Hypomorphic RAG Variant Identified by Newborn Screening: A Diagnostic and Treatment Dilemma
por: Chitty-Lopez, Maria, et al.
Publicado: (2020)